EVMN Evommune, Inc.
Price Chart
Executive Summary
Gregory S. Moss, an officer of Evommune, filed a Form 144 on May 28, 2026, indicating intent to sell 14,223 shares of common stock valued at approximately $331,965. The shares were acquired through the exercise of stock options on the same day, and the sale is planned for the open market via Morgan Stanley. This insider sale follows three other insider sales totaling $871K over the past 30 days, creating a pattern of insider selling at a company with a $745M market cap and strong analyst consensus.
Actionable Insight
The pattern of multiple insider sales (4 in 30 days) at a pre-revenue biotech with strong analyst coverage is a cautionary signal. Monitor for additional Form 144 or Form 4 filings from other insiders. The stock has shown negative momentum (avg -14% T+20 on prior reports), suggesting the market may already be pricing in insider de-risking ahead of clinical catalysts.
Key Facts
- Officer Gregory S. Moss filed Form 144 to sell 14,223 shares of common stock.
- Proposed sale value is approximately $331,965 based on filing date price.
- Shares were acquired via exercise of stock options on the same day (May 28, 2026).
- Sale is planned for open market execution through Morgan Stanley.
- This is the 4th insider sale in the last 30 days, totaling over $1.2M in proposed/actual insider selling.
- Company has a $745M market cap with 94% analyst bullish rating (16 Buy, 1 Hold).
Financial Impact
Proposed sale of $331,965 by an officer, representing approximately 0.04% of market cap.
Risk Factors
- Insider selling pattern may indicate lack of confidence ahead of clinical data readouts.
- Stock has underperformed significantly (avg -14% T+20 on prior reports), suggesting persistent selling pressure.
- Pre-revenue biotech with high cash burn — insider sales could signal concerns about runway or pipeline progress.
Market Snapshot
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-005228 |
| Document: 0001950047-26-005228-index.html | 0001950047-26-005228 |
| Document: 0001950047-26-005228.txt | 0001950047-26-005228 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 4, 2026
11d ago
|
Insider Cluster
| $20.69 $19.92 | ▲ +3.72% | ▲ +1.12% | $19.83 (+4.16%) |
|
Jun 2, 2026
12d ago
|
144
| $19.73 $20.69 | ▲ +4.87% | ▲ +4.47% | $19.83 (+0.51%) |
|
Jun 2, 2026
13d ago
|
Insider Cluster
| $19.82 $19.73 | ▼ −0.45% | ▲ +0.27% | $19.83 (+0.05%) |
|
May 28, 2026
17d ago
|
144
| $23.23 $22.17 | ▲ +4.56% | ▲ +4.82% | $19.83 (+14.64%) |
|
Apr 27, 2026
7w ago
|
EFFECT
| $25.00 $25.58 | ▲ +2.32% | ▲ +2.81% | $19.83 (−20.68%) |
|
Apr 21, 2026
7w ago
|
DEFA14A
| $27.12 $25.84 | ▼ −4.72% | ▼ −4.33% | $19.83 (−26.88%) |
|
Apr 17, 2026
8w ago
|
S-1
| $27.97 $28.07 | ▲ +0.36% | ▲ +1.01% | $19.83 (−29.10%) |
|
Apr 13, 2026
8w ago
|
8-K
| $26.63 $26.94 | ▲ +1.16% | ▲ +0.39% | $19.83 (−25.54%) |
|
Mar 5, 2026
14w ago
|
8-K
| $26.50 $24.61 | ▼ −7.13% | ▼ −7.98% | $19.83 (−25.17%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access